Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients

BACKGROUND: Hospitalized acutely ill medical patients are at risk for fatal and major thromboembolic events. Whether use of extended-duration primary thromboprophylaxis can prevent such events is unknown. OBJECTIVES: The purpose of this study was to evaluate whether extended-duration rivaroxaban red...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Coll Cardiol
Main Authors: Spyropoulos, Alex C., Ageno, Walter, Albers, Gregory W., Elliott, C. Gregory, Halperin, Jonathan L., Hiatt, William R., Maynard, Gregory A., Steg, P. Gabriel, Weitz, Jeffrey I., Lu, Wentao, Spiro, Theodore E., Barnathan, Elliot S., Raskob, Gary. E.
Formato: Artigo
Idioma:Inglês
Publicado em: The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7308003/
https://ncbi.nlm.nih.gov/pubmed/32586587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2020.04.071
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados